Stability of the irritable bowel syndrome and subgroups as measured by three diagnostic criteria - A 10-year follow-up study

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 5, 2010, Pages 670-680

  Olafsdottir, L B ^a   Gudjonsson, H ^a   Jonsdottir, H H ^b   Thjodleifsson, B ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DYSPEPSIA; FEMALE; FOLLOW UP; HEARTBURN; HUMAN; ICELAND; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; ICELAND; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; QUESTIONNAIRES; STATISTICS AS TOPIC; TIME FACTORS;

EID: 77955149924     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04388.x     Document Type: Article

References (50)

1. Drossman DA (ed Corrazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, Whitehead WE. Rome III: The Functional Gastrointestinal Disorders. 3rd ed. McLean, VA : Degnon Associates, 2006 : 374 381.
2. Hungin APS, Chang L, Locke GR, Dennis EH, Barghouts V. Irritable bowel syndrome in the United States: Prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005 21 : 1365 1375.
3. Talley N. Irritable bowel syndrome: definition, diagnosis and epidemiology. Clin Gastroenterology 1999 13 : 371 384. (Pubitemid 29537350)
4. Hungin APS, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003 17 : 643 650.
5. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis 1993 38 : 1569 1580.
6. Paré P, Gray J, Lam S, et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcome Study of GastroIntestinal Symptoms in Canada), a Naturalistic Study. Clinical Therapeutice 2006 28 : 1726 1735.
7. Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion 1999 60 : 77 81.
8. Everhart JE, Renault P. Irritable bowel syndrome in officebased practice in the United States. Gastroenterology 1991 100 : 998 1005.
9. Thompson W. The treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2002 16 : 1395 1406.
10. Akhter AJ, Shaheen M, Zha J. Organic colonic lesions in patients with Irritable Bowel Syndrome (IBS). Med Sci Monit 2006 12 : 363 367.
11. Quigley EMM, Bytzer P, Jones R, Mearin F. Irritable bowel syndrome: the burden and unmet needs in Europe. Dig Liver Dis 2006 38 : 717 723.
12. Bommelaer G, Poynard T, Le Pen C, et al. Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol 2004 28 : 554 561.
13. Sperber AD, Shvartzman P, Friger M, Fich A. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome? Eur J Gastroenterol Hepatol 2007 19 : 441 447.
14. Sperber AD, Shvartzman P, Friger M, Fich A. Unexpectedly low prevalence rates of IBS among adult Israeli Jews. Neurogastroenterol Motil 2005 17 : 207 211.
15. Manning AP, Thompson W, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978 2 : 653 654.
16. Drossman DA (ed), Richter J, Talley NJ, et al. The functional gastrointestinal disorders. Diagnosis, Pathophysiology and Treatment - A Multinational Consensus. Boston, US : Little Brown and Co, 1994.
17. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999 45 : 1143 1147.
18. Drossman D. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006 130 : 1377 1390.
19. Whitehead WE, Drossman DA. Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol 2010 105 : 814 820.
20. Bond B, Quinlan J, Dukes GE, Mearin F, Clouse RE, Alpers DH. Irritable bowel syndrome: more than abdominal pain and bowel habit abnormalities. Clin Gastroenterol Hepatol 2009 7 : 73 9.
21. Longstreth GF, Yao J. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004 126 : 1665 1673.
22. Bouin M, Plourde V, Boivin M, et al. Rectal distension testing in patients with irritable bowel syndrome: sensitivity, specificity and predictive values of pain sensory thresholds. Gastroenterology 2002 122 : 1771 1777.
23. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with bowel syndrome. Gastroenterology 1995 109 : 40 52.
24. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006 130 : 1480 1491.
25. Camilleri M, Chey WY, Mayer EA, et al. A randomized controller clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med 2001 161 : 1733 1740.
26. Müller-Lissner SA, Fumagalli I, Bardhan KD, et al. Tegaserod, 1 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001 15 : 1655 1666.
27. Penston JG, Pounder R. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996 10 : 83 9.
28. El-Serag HB, Talley N. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004 19 : 643 654.
29. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992 304 : 87 90.
30. Halder SLS, Locke G, Schleck CD, Zinsmeister AR, Melton LJ III., Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year Longitudinal Population-Based Study. Gastroenterology 2007 133 : 799 807.
31. Garrigues V, Mearin F, Badía X, et al. Change over time of bowel habits in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study). Aliment Pharmacol Ther 2007 25 : 323 332.
32. Ford AC, Forman D, Bailey AG, Axon ATR, Moayyedi P. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol 2007 103 : 957 965.
33. Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Thjodleifsson B. Natural history of functional dyspepsia - a 10-year population-based study. Digestion 2010 81 : 53 61.
34. Ólafsdóttir LB, Gudjonsson H, Thjodleifsson B. Epidemiological study of functional bowel disorders in Iceland. Icelandic Med J 2005 91 : 329 333.
35. Dillman D. Mail and Telephon Surveys: The Total Design Method. John Wiley and Sons : A Wiley-Interscience Publication, 1978.
36. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton J III. Assessment of functional gastrointestinal disease: the Bowel Disease Questionnaire. Mayo Clin Proc 1990 65 : 1456 1479.
37. Talley NJ, Phyllips SF, Melton LJ III., et al. A patient questionnaire to identify bowel disaese. Ann Intern Med 1989 111 : 671 674.
38. Attanasio V, Andrsik F, Blanchard EB, et al. Psychometric prperties of the SUNYA revision of the Psychosomatic Symptom Checklist. J Behav Med 1984 7 : 247 257.
39. Talley NJ, Zinsmeister A, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991 101 : 927 934.
40. Drossman D. A questionnaire for functional bowel disorders. Ann Intern Med 1989 111 : 627 629.
41. Heaton KW, Gosh S. Relation between stool form on a seven point scale and symptoms of urgency, straining, and incomplete evacuation: a new way of looking at irritable bowel syndrome. Gut 1989 30 : 1465.
42. O'Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ 1990 300 : 439 440.
43. Probert CS, Emmett PM, Cripps HA, Heaton KW. Evidence for the ambiguity of the term constipation: the role of irritable bowel syndrome. Gut 1994 35 : 1455 1458.
44. Dorn SD, Morris CB, Hu Y, et al. Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar. J Clin Gastroenterol 2009 43 : 214 220.
45. Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005 128 : 580 589.
46. Longstreth GF, Wilson A, Knight K, et al. Irritable bowel syndrome, health care use, and costs: a US managed care perspective. Am J Gastroenterol 2003 98 : 600 607.
47. Eisen GM, Weinfurt KP, Hurley J, et al. The economic burden of irritable bowel syndrome in a managed care organization. Am J Gastroenterol 2000 95 : 2628 2629.
48. Martin BC, Ganguly R, Pannicker S, Frech F, Barghout V. Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome. Curr Med Res Opin 2003 19 : 771 780.
49. Wang AJ, Liao XH, XiShou LS, et al. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC Gastroenterol 2008 8 : 1 7.
50. Corsetti M, Caenepeel P, Fischler B, Janseens J, Tack J. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol 2004 99 : 1152 1159.